Long-Term Outcome of Unrelated Donor Transplantation for AML Using Myeloablative Conditioning Incorporating Pretransplant Alemtuzumab
Open Access
- 30 June 2007
- journal article
- clinical trial
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 13 (6) , 724-733
- https://doi.org/10.1016/j.bbmt.2007.02.011
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: results from the multicenter German cooperative study groupBone Marrow Transplantation, 2005
- How to improve the search for an unrelated haematopoietic stem cell donor. Faster is better than more!Bone Marrow Transplantation, 2005
- Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcomeBlood, 2004
- Matched and Mismatched Allogeneic Stem-Cell Transplantation From Unrelated Donors Using Combined Graft-Versus-Host Disease Prophylaxis Including Rabbit Anti–T Lymphocyte GlobulinJournal of Clinical Oncology, 2003
- Tissue typing in support of unrelated hematopoietic cell transplantationTissue Antigens, 2003
- Association between pretransplant Thymoglobulin and reduced non-relapse mortality rate after marrow transplantation from unrelated donorsBone Marrow Transplantation, 2002
- Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)Blood, 2001
- The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemiaBone Marrow Transplantation, 2000
- Prospective Randomized Multicenter Study Comparing Cyclosporin Alone Versus the Combination of Antithymocyte Globulin and Cyclosporin for Treatment of Patients With Nonsevere Aplastic Anemia: A Report From the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working PartyBlood, 1999
- T-cell depletion of HLA-identical transplants in leukemiaBlood, 1991